WallStreetZenWallStreetZen

NASDAQ: CGON
Cg Oncology Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

CGON past revenue growth

How has CGON's revenue growth performed historically?
Company
6.81%
Industry
144.63%
Market
17.55%
CGON's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CGON's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CGON's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CGON earnings and revenue history

Current Revenue
$204.0k
Current Earnings
-$67.8M
Current Profit Margin
-33,234.3%

CGON Return on Equity

Insufficient data to display

Be the first to know when CGON announces earnings.

CGON Return on Assets

Current Company
-39.1%
Current Industry
2.9%
CGON is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CGON Return on Capital Employed

Current Company
-30%
Current Industry
19.5%

CGON vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CGON$204.00k-$55.48M-$67.80M-85.97%N/A
ARWR$181.74M-$262.45M-$296.81M+30.90%N/A
ACLX$110.32M-$44.26M-$70.69MN/AN/A
MOR$259.00M-$41.75M-$206.23M+24.68%N/A
MLTX$0.00-$43.97M-$44.08MN/AN/A
View Top Biotech Stocks

Cg Oncology Earnings & Revenue FAQ

What were CGON's earnings last quarter?

Cg Oncology (NASDAQ: CGON) reported Q4 2023 earnings per share (EPS) of -$4.36, up 35.83% year over year. Total Cg Oncology earnings for the quarter were -$22.05 million. In the same quarter last year, Cg Oncology's earnings per share (EPS) was -$3.21.

If you're new to stock investing, here's how to buy Cg Oncology stock.

What was CGON's earnings growth in the past year?

As of Q2 2024, Cg Oncology's earnings has grown year over year. Cg Oncology's earnings in the past year totalled -$67.80 million.

What was CGON's revenue last quarter?

Cg Oncology (NASDAQ: CGON) reported Q4 2023 revenue of $1.00 thousand up Infinity% year over year. In the same quarter last year, Cg Oncology's revenue was $0.00.

What was CGON's revenue growth in the past year?

As of Q2 2024, Cg Oncology's revenue has grown 6.81% year over year. This is 137.82 percentage points lower than the US Biotechnology industry revenue growth rate of 144.63%. Cg Oncology's revenue in the past year totalled $204.00 thousand.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.